Canada Markets open in 5 hrs 8 mins

Revive Therapeutics Ltd. (RVVTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2202-0.0198 (-8.25%)
At close: 03:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.10
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.6000
52 Week Low 30.2153
50-Day Moving Average 30.3449
200-Day Moving Average 30.3753

Share Statistics

Avg Vol (3 month) 3749.65k
Avg Vol (10 day) 3583.16k
Shares Outstanding 5318.46M
Implied Shares Outstanding 6N/A
Float 8311.43M
% Held by Insiders 12.23%
% Held by Institutions 12.64%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jun. 29, 2021
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.96%
Return on Equity (ttm)-121.97%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.91M
Net Income Avi to Common (ttm)-20.47M
Diluted EPS (ttm)-0.0550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.82M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)395.8k
Total Debt/Equity (mrq)1.64
Current Ratio (mrq)4.32
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-9.15M
Levered Free Cash Flow (ttm)-5.6M